Deal Snapshot
Labcorp Completes Acquisition of Myriad Autoimmune´s Vectra Testing Business
Wednesday 15 September 2021

US-based life sciences company Labcorp (NYSE: LH) has closed its acquisition of select operating assets and intellectual property from Myriad Genetics' autoimmune business unit, including the Vectra rheumatoid arthritis assay, the company said.

Earlier this year, Labcorp entered into a definitive agreement to acquire Myriad's Vectra test, related IP and other RA assets, bolstering its scientific leadership in rheumatology.

Date Published: 15/09/2021